A collaboration with Loxo@Lilly, led by PC3I Associate Director Charu Aggarwal, will expand use of a novel strategy to help patients with lung cancer receive important genetic testing.
We apply the latest science to create, test, and scale solutions to address the most intractable problems in cancer care delivery.
We are change agents dedicated to designing, testing, scaling and disseminating innovations in cancer care.
In partnership with Gilead Sciences, a research team led by PC3I Faculty Lola Fayanju will focus on collection of social and behavioral determinants of health to improve health outcomes for patients with breast cancer.
Prehab to Rehab (P2R) is a home-based prehabilitation/rehabilitation program that aims to improve health outcomes for patients undergoing surgery for pancreatic cancer.
A team of researchers is working to reduce wait times for patients with non-cancerous blood disorders using e-consults as an alternative to face-to-face visits.
A new approach aims to shorten wait times and improve access to care for patients with gynecologic cancers through a decision tree aimed to streamline scheduling.